K50.1 K51.0 K51.2 K51.3 K50.88 K51.9 K75.4
Conditions
Interventions
Group 1: Vaccinations with varicella vaccine with documentation of side effects by questionnaires and assessment of effectivity by increment of specific antibodies.
Sponsors
Klinik für Kinder- und JugendmedizinUniversitätsklinikum Ulm
Eligibility
Sex/Gender
All
Age
2 Years to 18 Years
Inclusion criteria
Inclusion criteria: As this is an observational study no inclusion criteria are defined. In principal, patients with chronic inflammatory bowel disease or autoimmune hepatitis being in steady state of their disease and having the indication of varicella vaccination due to insufficient protection against varicella can participate.
Exclusion criteria
Exclusion criteria: As this is an observational study no exclusion criteria are given for this study. Basically the recommendations from the enclosed leaflet have to be followed. In addition, we made some recommendations in our observational protocol. 1) We need a parent or patient consent to collect and analyze the data in this study. 2) If the patient is suspicious for an immunodeficiency this should be clarified first. 3) In addition to the leaflet we do not recommend immunization during an active underlying disease 4) Furthermore, we specified some conditions that may affect safety and efficiency, which should be avoided. In detail these conditions are stated in the observational protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety of varicella vaccination using the immunological check list | — |
Secondary
| Measure | Time frame |
|---|---|
| Effectivity of vaccination with increment of vaccine specific antibody formation after 12-16 weeks | — |
Countries
Germany
Contacts
Public ContactCarsten Posovszky
Klinik für Kinder- und JugendmedizinUniversitätsklinikum Ulm
Outcome results
None listed